Minneapolis, MN4 Active Studies

Advanced Solid Tumors Clinical Trials in Minneapolis, MN

Find 4 actively recruiting advanced solid tumors clinical trials in Minneapolis, MN. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
829
Enrolling

Recruiting Advanced Solid Tumors Studies in Minneapolis

RecruitingMinneapolis, MNNCT04665206

Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors

This is an open-label, dose escalation and expansion study to evaluate the safety, tolerability, PK, and biological activity of VT3989 administered, alone or in combination, once daily in patients wit...

336 participants
Vivace Therapeutics, Inc
View Study Details
RecruitingMinneapolis, MNNCT03746431

A Phase 1 Study of [225Ac]-FPI-1434 Injection

This is a first-in-human Phase 1/2, non-randomized, multi-centre, open-label clinical study designed to investigate safety, tolerability, PK, and preliminary anti-tumour activity of \[225Ac\]-FPI-1434...

253 participants
Fusion Pharmaceuticals Inc.
View Study Details
RecruitingMinneapolis, MNNCT05267626

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

This is a first in human, open-label, multi-center Phase 1 / 2 study to evaluate the safety, tolerability, and initial efficacy of AU-007 in patients with advanced solid tumors. AU-007 will be adminis...

159 participants
Aulos Bioscience, Inc.
View Study Details
RecruitingMinneapolis, MNNCT06620302

Testing the Addition of an Anti-cancer Drug, DT2216, to the Usual Chemotherapy Treatment for Relapsed or Refractory Solid Tumors and Fibrolamellar Carcinoma

This phase I/II trial tests the safety, side effects and best dose of DT2216 in combination with irinotecan and how well it works in treating children, adolescents and young adults with solid tumors a...

81 participants
Children's Oncology Group
View Study Details

About Advanced Solid Tumors Clinical Trials in Minneapolis

Advanced solid tumors refer to cancers that have grown beyond the original site or spread to distant organs. Many clinical trials enroll patients with various types of advanced solid tumors to test novel therapies. These trials often investigate immunotherapy, targeted therapy, and combination approaches.

There are currently 4 advanced solid tumors clinical trials recruiting participants in Minneapolis, MN. These studies are seeking a combined 829 participants. Research is being sponsored by Vivace Therapeutics, Inc, Fusion Pharmaceuticals Inc., Aulos Bioscience, Inc. and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Advanced Solid Tumors Clinical Trials in Minneapolis — FAQ

Are there advanced solid tumors clinical trials in Minneapolis?

Yes, there are 4 advanced solid tumors clinical trials currently recruiting in Minneapolis, MN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Minneapolis?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Minneapolis research site will contact you about next steps.

Are clinical trials in Minneapolis free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Minneapolis studies also compensate for your time and travel.

What advanced solid tumors treatments are being tested?

The 4 active trials in Minneapolis are testing new therapies including novel drugs, biologics, and treatment approaches for advanced solid tumors.

Data updated March 2, 2026 from ClinicalTrials.gov